11.1 Information on toxicological effects
Acute toxicity
LD50 Oral - Rat - male - 1,620 mg/kg
Remarks: (ECHA)
The value is given in analogy to the following substances: Cyclohexanone
Symptoms: Stomach/intestinal disorders, Risk of aspiration upon vomiting., Aspiration may cause pulmonary edema and pneumonitis.
LC50 Inhalation - Rat - male and female - 4 h - > 6.2 mg/l - vapor
Remarks: (ECHA)
The value is given in analogy to the following substances: Cyclohexanone
Symptoms: In high doses:, Irritation symptoms in the respiratory tract.
LD50 Dermal - Rabbit - 1,100 mg/kg
Remarks: (External MSDS)
The value is given in analogy to the following substances: Cyclohexanone
Skin corrosion/irritation
Skin - Rabbit
Result: Irritating to skin. - 4 h (OECD Test Guideline 404)
Remarks: The value is given in analogy to the following substances: Cyclohexanone
Remarks: Repeated or prolonged exposure may cause skin irritation and dermatitis, due to degreasing properties of the product.
Serious eye damage/eye irritation
Eyes - In vitro study
Result: Irreversible effects on the eye
Remarks: (ECHA)
The value is given in analogy to the following substances: Cyclohexanone
Remarks: Risk of corneal clouding.
Respiratory or skin sensitization
Maximization Test - Guinea pig
Result: negative
Remarks: (ECHA)
The value is given in analogy to the following substances: Cyclohexanone
Germ cell mutagenicity
Test Type: In vitro mammalian cell gene mutation test
Test system: Chinese hamster ovary cells
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 476
Result: negative
Remarks: The value is given in analogy to the following substances: CyclohexanoneTest
Type: Ames test
Test system: Escherichia coli/Salmonella typhimurium
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 471
Result: negative
Remarks: The value is given in analogy to the following substances: CyclohexanoneTest
Type: unscheduled DNA synthesis assay
Test system: human diploid fibroblasts
Metabolic activation: with and without metabolic activation
Method: OECD Test Guideline 482
Result: negative
Remarks: The value is given in analogy to the following substances: Cyclohexanone
Test Type: Micronucleus test
Species: Mouse
Cell type: Bone marrow
Application Route: Oral
Method: OECD Test Guideline 474
Result: negative
Remarks: The value is given in analogy to the following substances: Cyclohexanone
Carcinogenicity
Classified based on available data. For more details, see section 2
Reproductive toxicity
Classified based on available data. For more details, see section 2
Specific target organ toxicity - single exposure
Inhalation - May cause respiratory irritation. - Respiratory Tract
Remarks: The value is given in analogy to the following substances: Cyclohexanone
Specific target organ toxicity - repeated exposure
Classified based on available data. For more details, see section 2
Aspiration hazard
Classified based on available data. For more details, see section 2
11.2 Additional Information
Repeated dose toxicity - Rat - male and female - Oral - 3 Months - NOAEL (No observed adverse effect level) - 143 mg/kg
Remarks: The value is given in analogy to the following substances: Cyclohexanone
Prolonged or repeated exposure to skin causes defatting and dermatitis., burning sensation, Cough, wheezing, laryngitis, Shortness of breath, Headache, Nausea, Vomiting,
Central nervous system depression, Incoordination., To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly investigated.
Systemic effects:
After absorption of large quantities:
Headache
Salivation
Nausea
Vomiting
Dizziness narcosis
Coma
The following applies to ketones in general: when vapours/aerosols occur, mucosal irritations, coughing, and dyspnoea after inhalation. The absorption of large quantities leads to: CNS depression (narcosis). Repeated skin contact leads to a degreasing effect, with secondary inflammation possible. Toxic effects on the liver and kidneys cannot be excluded after high doses. The inhalation of droplets may result in the formation of oedemas in the respiratory tract.
Other dangerous properties can not be excluded.
Handle in accordance with good industrial hygiene and safety practice.